Related references
Note: Only part of the references are listed.Nadofaragene Firadenovec: First Approval (vol 83, pg 353, 2023)
Arnold Lee
DRUGS (2023)
Genetic characterization of human adenoviruses in patients using metagenomic next-generation sequencing in Hubei, China, from 2018 to 2019
Bin Fang et al.
FRONTIERS IN MICROBIOLOGY (2023)
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
Shaza S. Issa et al.
CELLS (2023)
Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies
Ana Sofia Coroadinha
CELLS (2023)
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial
Elisa Magrin et al.
NATURE MEDICINE (2022)
Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapy
Joseph Hoare et al.
COMMUNICATIONS BIOLOGY (2022)
The Hippo signaling component LATS2 enhances innate immunity to inhibit HIV-1 infection through PQBP1-cGAS pathway
Tian-Sheng He et al.
CELL DEATH AND DIFFERENTIATION (2022)
Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates
Michela Milani et al.
NATURE COMMUNICATIONS (2022)
Impact of Manufacturing Procedures on CAR T Cell Functionality
Norihiro Watanabe et al.
FRONTIERS IN IMMUNOLOGY (2022)
HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy
Amanda Rosewell Shaw et al.
CANCERS (2022)
Lentiviral Gene Therapy for Artemis-Deficient SCID
Morton J. J. Cowan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
Wen-Chien Wang et al.
VIRUSES-BASEL (2022)
Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer
Kaiyi Yang et al.
BIOMEDICINES (2022)
Valoctocogene Roxaparvovec: First Approval
Hannah A. Blair
DRUGS (2022)
Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing
Nina Kessler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2022)
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma
Tira J. Tan et al.
NATURE COMMUNICATIONS (2022)
In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy
Yingyu Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease
Margaret Ryan et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Overcoming innate immune barriers that impede AAV gene therapy vectors
Manish Muhuri et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Concepts in Oncolytic Adenovirus Therapy
Klaus Mantwill et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancer
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2021)
Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
Florian Kreppel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
Lindsey A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
B. Gentner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
Ying Kai Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Adenovirus Core Proteins: Structure and Function
Shermila Kulanayake et al.
VIRUSES-BASEL (2021)
Lentiviral Vector Bioprocessing
Christopher Perry et al.
VIRUSES-BASEL (2021)
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
Maki Watanabe et al.
VIRUSES-BASEL (2021)
VEGFA165 gene therapy ameliorates blood-labyrinth barrier breakdown and hearing loss
Jinhui Zhang et al.
JCI INSIGHT (2021)
Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
Shuangyou Liu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector
Sungjin Lee et al.
BIOMATERIALS (2021)
Less phagocytosis of viral vectors by tethering with CD47 ectodomain
Esmael M. Alyami et al.
JOURNAL OF MATERIALS CHEMISTRY B (2021)
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
Thomas Leth Jensen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
Cristina Olgasi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial
Victor Moreno et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII
Athena L. Russell et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
John W. Day et al.
DRUG SAFETY (2021)
Elivaldogene Autotemcel: First Approval
Susan J. Keam
MOLECULAR DIAGNOSIS & THERAPY (2021)
Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
Toni S. Pearson et al.
NATURE COMMUNICATIONS (2021)
Dodging the Host Interferon-Stimulated Gene Mediated Innate Immunity by HIV-1: A Brief Update on Intrinsic Mechanisms and Counter-Mechanisms
Kumaraswami Chintala et al.
FRONTIERS IN IMMUNOLOGY (2021)
Effect of CpG Depletion of Vector Genome on CD8+ T Cell Responses in AAV Gene Therapy
Thais B. Bertolini et al.
FRONTIERS IN IMMUNOLOGY (2021)
Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapy TABLE OF CONTENTS
Chuang Wu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2021)
The cGAS-STING pathway as a therapeutic target in inflammatory diseases
Alexiane Decout et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Cytokine-induced killer cells carrying recombinant oncolytic adenovirus expressing p21Ras scFv inhibited liver cancer
Fang Dai et al.
JOURNAL OF CANCER (2021)
Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
Martina Schuessler-Lenz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma
Sahra Ali et al.
ONCOLOGIST (2020)
Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery
Michael J. Castle et al.
HUMAN GENE THERAPY (2020)
Immune Responses to Viral Gene Therapy Vectors
Jamie L. Shirley et al.
MOLECULAR THERAPY (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Lentiviral gene therapy for X-linked chronic granulomatous disease
Donald B. Kohn et al.
NATURE MEDICINE (2020)
Engineering adeno-associated virus vectors for gene therapy
Chengwen Li et al.
NATURE REVIEWS GENETICS (2020)
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia A Nonrandomized Controlled Trial
M. Dominik Fischer et al.
JAMA OPHTHALMOLOGY (2020)
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
Giuseppe Ronzitti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
Mizuho Sato-Dahlman et al.
CANCERS (2020)
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy A Nonrandomized Controlled Trial
Jerry R. Mendell et al.
JAMA NEUROLOGY (2020)
Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity
Carolina B. Ferreira et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
AAV9-DOK7 gene therapy reduces disease severity in Smn2B/- SMA model mice
Kevin A. Kaifer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
Lindsey A. George et al.
MOLECULAR THERAPY (2020)
Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
Yu Xia et al.
CURRENT GENE THERAPY (2020)
Gene Therapy Applications of Non-Human Lentiviral Vectors
Altar M. Munis
VIRUSES-BASEL (2020)
MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway
Mingfu Tian et al.
CELL REPORTS (2020)
Systemic cancer therapy with engineered adenovirus that evades innate immunity
Svetlana Atasheva et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Biosilicified oncolytic adenovirus for cancer viral gene therapy
Hao Kong et al.
BIOMATERIALS SCIENCE (2020)
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K. John Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Modulation of immune responses in lentiviral vector-mediated gene transfer
Andrea Annoni et al.
CELLULAR IMMUNOLOGY (2019)
The effect of gene therapy on postoperative recurrence of small hepatocellular carcinoma (less than 5cm)
Jian Meng et al.
CANCER GENE THERAPY (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
X-linked myotubular myopathy A prospective international natural history study
Melanie Annoussamy et al.
NEUROLOGY (2019)
Adeno-Associated Virus (AAV) Versus Immune Response
Joseph Rabinowitz et al.
VIRUSES-BASEL (2019)
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Qiaoqiao Xiao et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
Elisabeth A. Spronck et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy
Peng Lv et al.
NANO LETTERS (2019)
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
Ewelina Mamcarz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates
Michela Milani et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice
Chen-Ye Zeng et al.
NEUROBIOLOGY OF AGING (2019)
Gene Therapy
Katherine A. High et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Genetic strategy to decrease complement activation with adenoviral therapies
Christopher M. Gentile et al.
PLOS ONE (2019)
Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
Tahir Muhammad et al.
STEM CELL RESEARCH & THERAPY (2019)
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Allison M. Keeler et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate
Bence Gyorgy et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Interplay between Intrinsic and Innate Immunity during HIV Infection
Louis Bergantz et al.
CELLS (2019)
Adenoviral strategies to overcome innate cellular responses to infection
Sook-Young Sohn et al.
FEBS LETTERS (2019)
Innate immunity to adenovirus: lessons from mice
Svetlana Atasheva et al.
FEBS LETTERS (2019)
Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
Gerard A. Rodrigues et al.
PHARMACEUTICAL RESEARCH (2019)
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
Raygene Martier et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
Brennetta J. Crenshaw et al.
BIOMEDICINES (2019)
Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Min Liang
CURRENT CANCER DRUG TARGETS (2018)
Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy
Mark E. Pennesi et al.
HUMAN GENE THERAPY (2018)
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy
Yu Xia et al.
HUMAN GENE THERAPY (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination
Maria Bottermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses
Lorena de Pablo-Maiso et al.
VIRUSES-BASEL (2018)
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
Carolina Petrillo et al.
CELL STEM CELL (2018)
Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction
Wenwei Shao et al.
JCI INSIGHT (2018)
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B
Wolfgang Miesbach et al.
BLOOD (2018)
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Tien V. Nguyen et al.
ONCOLYTIC VIROTHERAPY (2018)
Nonintegrating Gene Therapy Vectors
Takis Athanasopoulos et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo
Shuangli Xiao et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell et al.
LANCET (2017)
Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV
Bence Gyorgy et al.
MOLECULAR THERAPY (2017)
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
Florian Eichler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth
Paul D. Bryson et al.
VACCINE (2017)
Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease
Jackalina M. Van Kampen et al.
PLOS ONE (2017)
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
Francesco Piras et al.
EMBO MOLECULAR MEDICINE (2017)
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Daniel H. Sterman et al.
CLINICAL CANCER RESEARCH (2016)
Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
Joana Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
Mario Sessa et al.
LANCET (2016)
Adenovirus VA RNA: An essential pro-viral non-coding RNA
Virginia K. Vachon et al.
VIRUS RESEARCH (2016)
Cellular Innate Immunity and Restriction of Viral Infection: Implications for Lentiviral Gene Therapy in Human Hematopoietic Cells
Anna Kajaste-Rudnitski et al.
HUMAN GENE THERAPY (2015)
Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
Quan-shun Wang et al.
MOLECULAR THERAPY (2015)
The Challenge for Gene Therapy: Innate Immune Response to Adenoviruses
Bart Thaci et al.
Oncotarget (2015)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
Hong Jiang et al.
PLOS ONE (2014)
Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them
Sangeetha Hareendran et al.
REVIEWS IN MEDICAL VIROLOGY (2013)
Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
Tolga Sutlu et al.
HUMAN GENE THERAPY (2012)
A TLR and Non-TLR Mediated Innate Response to Lentiviruses Restricts Hepatocyte Entry and Can be Ameliorated by Pharmacological Blockade
Judith Agudo et al.
MOLECULAR THERAPY (2012)
Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
Seppo Ylae-Herttuala
MOLECULAR THERAPY (2012)
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver
Ashley T. Martino et al.
BLOOD (2011)
Adenovirus Virus-Associated RNAs Induce Type I Interferon Expression through a RIG-I-Mediated Pathway
Takeharu Minamitani et al.
JOURNAL OF VIROLOGY (2011)
Adeno-Associated Virus Activates an Innate Immune Response in Normal Human Cells but Not in Osteosarcoma Cells
Leila N. Laredj et al.
JOURNAL OF VIROLOGY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Innate immunity modulation in virus entry
Mathias Faure et al.
CURRENT OPINION IN VIROLOGY (2011)
Innate immune responses to AAV vectors
Geoffrey L. Rogers et al.
FRONTIERS IN MICROBIOLOGY (2011)
ADENOVIRUS-TRIGGERED INNATE SIGNALLING PATHWAYS
G. Fejer et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2011)
Recognition of Virus Infection and Innate Host Responses to Viral Gene Therapy Vectors
Dmitry M. Shayakhmetov et al.
MOLECULAR THERAPY (2010)
Induction of type I interferon by adenovirus-encoded small RNAs
Tomoko Yamaguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice
Jiangao Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy
Sergey S. Seregin et al.
MOLECULAR THERAPY (2009)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance
Brian D. Brown et al.
BLOOD (2007)
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector
Scott E. Hensley et al.
MOLECULAR THERAPY (2007)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Recombinant AAV-mediated gene delivery to the central nervous system
L Tenenbaum et al.
JOURNAL OF GENE MEDICINE (2004)
Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes
BG Harvey et al.
MOLECULAR THERAPY (2002)
Share Paper
